Cavitation Properties of Block Copolymer Stabilized Phase-Shift Nanoemulsions Used as Drug Carriers

Ultrasound in Medicine and Biology

Volumn 36, Issue 3, 2010, Pages 419-429

  Rapoport, Natalya ^a   Christensen, Douglas A ^a   Kennedy, Anne M ^b   Nam, Kweon Ho ^a  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acoustic droplet vaporization; Cavitation; Microbubbles; Nanoemulsions

Indexed keywords

ACOUSTIC CAVITATIONS; ACOUSTIC DROPLET VAPORIZATION; AMPHIPHILIC BLOCK COPOLYMERS; DRUG CARRIER; FOCUSED ULTRASOUND; HYDROPHOBIC BLOCKS; INERTIAL CAVITATION; LIQUID EMULSIONS; LIQUID MATRIX; MICROBUBBLES; NANO-EMULSIONS; PLLA; POLY (L-LACTIDE); STABLE CAVITATION; ULTRASOUND PRESSURE;

ACOUSTIC WAVES; BLOCK COPOLYMERS; BUBBLES (IN FLUIDS); CONTROLLED DRUG DELIVERY; COPOLYMERIZATION; DROP FORMATION; EMULSIONS; ETHYLENE; GELS; INSECTICIDES; LIQUIDS; ORGANIC POLYMERS; POLYCAPROLACTONE; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; TISSUE; ULTRASONICS; VAPORIZATION;

CAVITATION;

COPOLYMER; PERFLUOROPENTANE; POLY(ETHYELENE OXIDE CO CAPROLACTONE); POLY(ETHYELENE OXIDE CO LACTIC ACID); UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG TARGETING; HIGH INTENSITY FOCUSED ULTRASOUND; MICROBUBBLE; NANOEMULSION; PARTICLE SIZE; PRESSURE; PRIORITY JOURNAL; VAPORIZATION;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; LACTATES; MICROBUBBLES; NANOPARTICLES; PARTICLE SIZE; PHASE TRANSITION; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 76749096205     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2009.11.009     Document Type: Article

References (41)

1. Barber E.J., and Cady G.H. Vapor pressures of perfluoropentanes. J Phys Chem 60 (1956) 504-505
2. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., and Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108 (2003) 1022-1026
3. Campbell R.B. Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 6 (2006) 503-512
4. Chang P.P., Chen W.S., Mourad P.D., Poliachik S.L., and Crum L.A. Thresholds for inertial cavitation in albunex suspensions under pulsed ultrasound conditions. IEEE Trans Ultrason Ferroelectr Freq Control 48 (2001) 161-170
5. Chappell J.C., Klibanov A.L., and Price R.J. Ultrasound-microbubble-induced neovascularization in mouse skeletal muscle. Ultrasound Med Biol 31 (2005) 1411-1422
6. Chen W.S., Brayman A.A., Matula T.J., and Crum L.A. Inertial cavitation dose and hemolysis produced in vitro with or without Optison. Ultrasound Med Biol 29 (2003) 725-737
7. Church C.C., and Carstensen E.L. Stable' inertial cavitation. Ultrasound Med Biol 27 (2001) 1435-1437
8. Clasohm L.Y., Vakarelski I.U., Dagastine R.R., Chan D.Y., Stevens G.W., and Grieser F. Anomalous pH dependent stability behavior of surfactant-free nonpolar oil drops in aqueous electrolyte solutions. Langmuir 23 (2007) 9335-9340
9. Datta S., Coussios C.C., Ammi A.Y., Mast T.D., de Courten-Myers G.M., and Holland C.K. Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. Ultrasound Med Biol 34 (2008) 1421-1433
10. Dayton P.A., Zhao S., Bloch S.H., Schumann P., Penrose K., Matsunaga T.O., Zutshi R., Doinikov A., and Ferrara K.W. Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging 5 (2006) 160-174
11. Ferrara K., Pollard R., and Borden M. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9 (2007) 415-447
12. Ferrara K., Borden M., and Zhang H. Lipid-shelled vehicles: Engineering for ultrasound molecular imaging and drug delivery. Acc Chem Re (2009) PMID: 19552457
13. Gao Z., Kennedy A.M., Christensen D.A., and Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 48 (2008) 260-270
14. Giesecke T., and Hynynen K. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. Ultrasound Med Biol 29 (2003) 1359-1365
15. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., and Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 24 (1998) 587-595
16. Hernot S., and Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60 (2008) 1153-1166
17. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., and Jain R.K. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95 (1998) 4607-4612
18. Holland C.K., and Apfel R.E. Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J Acoust Soc Am 88 (1990) 2059-2069
19. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 60 (2008) 1209-1217
20. Iyer A.K., Khaled G., Fang J., and Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11 (2006) 812-818
21. Kinoshita M., McDannold N., Jolesz F.A., and Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A 103 (2006) 11719-11723
22. Kripfgans O.D., Fabiilli M.L., Carson P.L., and Fowlkes J.B. On the acoustic vaporization of micrometer-sized droplets. J Acoust Soc Am 116 (2004) 272-281
23. Kripfgans O.D., Fowlkes J.B., Miller D.L., Eldevik O.P., and Carson P.L. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 26 (2000) 1177-1189
24. Lo A.H., Kripfgans O.D., Carson P.L., Rothman E.D., and Fowlkes J.B. Acoustic droplet vaporization threshold: effects of pulse duration and contrast agent. IEEE Trans Ultrason Ferroelectr Freq Control 54 (2007) 933-946
25. Mehier-Humbert S., Yan F., Frinking P., Schneider M., Guy R.H., and Bettinger T. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem 18 (2007) 652-662
26. Miller D.L., Averkiou M.A., Brayman A.A., Everbach E.C., Holland C.K., Wible Jr. J.H., and Wu J. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 27 (2008) 611-632 quiz 33-36
27. Miller D.L., and Gies R.A. The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine. Ultrasound Med Biol 24 (1998) 123-128
28. Rapoport N., Marin A., and Christensen D.A. Ultrasound-activated micellar drug delivery. Drug Delivery Syst Sci 2 (2002) 37-46
29. Rapoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. In: Amiji M. (Ed). Nanotechnology for cancer therapy (2006), CRC Press, Boca Raton, FL 417-437
30. Rapoport N. Tumor targeting by polymeric assemblies and ultrasound activation. In: Arshadi R., and Kono K. (Eds). MML (2006), Kentus Books, London, UK 305-362
31. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 32 (2007) 962-990
32. Rapoport N., Gao Z., and Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99 (2007) 1095-1106
33. Rapoport N., Kennedy A.M., Shea J.E., Scaife C.L., and Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 138 (2009) 268-276
34. Rapoport N.Y., Efros A.L., Christensen D.A., Kennedy A.M., and Nam K.H. Microbubble generation in phase-shift nanoemulsions used as anticancer drug carriers. Bub Sci Eng Tech 1 (2009) 31-39
35. Schroeder A., Avnir Y., Weisman S., Najajreh Y., Gabizon A., Talmon Y., Kost J., and Barenholz Y. Controlling liposomal drug release with low frequency ultrasound: Mechanism and feasibility. Langmuir 23 (2007) 4019-4025
36. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., and Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 98 (1998) 290-293
37. Stieger S.M., Caskey C.F., Adamson R.H., Qin S., Curry F.R., Wisner E.R., and Ferrara K.W. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 243 (2007) 112-121
38. Suzuki R., Takizawa T., Negishi Y., Hagisawa K., Tanaka K., Sawamura K., Utoguchi N., Nishioka T., and Maruyama K. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 117 (2007) 130-136
39. ter Haar G.R. Ultrasonic biophysics (2004), Wiley, Chichester, UK
40. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., and Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 56 (2004) 1291-1314
41. Wheatley M.A., Forsberg F., Oum K., Ro R., and El-Sherif D. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. Ultrasonics 44 (2006) 360-367